WallStreetZenWallStreetZen

NASDAQ: SRTS
Sensus Healthcare Inc Stock

$3.38+0.24 (+7.64%)
Updated Apr 12, 2024
SRTS Price
$3.38
Fair Value Price
-$0.61
Market Cap
$55.41M
52 Week Low
$1.79
52 Week High
$5.38
P/E
112.67x
P/B
1.13x
P/S
1.57x
PEG
N/A
Dividend Yield
N/A
Revenue
$24.41M
Earnings
$485.00k
Gross Margin
57.6%
Operating Margin
2.67%
Profit Margin
2%
Debt to Equity
0.1
Operating Cash Flow
-$2M
Beta
0.86
Next Earnings
May 1, 2024
Ex-Dividend
N/A
Next Dividend
N/A

SRTS Overview

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SRTS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SRTS ($3.38) is overvalued by 653.62% relative to our estimate of its Fair Value price of -$0.61 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
SRTS ($3.38) is not significantly undervalued (653.62%) relative to our estimate of its Fair Value price of -$0.61 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SRTS was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SRTS due diligence checks available for Premium users.

Be the first to know about important SRTS news, forecast changes, insider trades & much more!

SRTS News

Valuation

SRTS fair value

Fair Value of SRTS stock based on Discounted Cash Flow (DCF)
Price
$3.38
Fair Value
-$0.61
Undervalued by
653.62%
SRTS ($3.38) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SRTS ($3.38) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SRTS was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SRTS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
112.67x
Industry
29.43x
Market
42.64x
SRTS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SRTS is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

SRTS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.13x
Industry
3.74x
SRTS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SRTS's financial health

Profit margin

Revenue
$12.6M
Net Income
$4.2M
Profit Margin
33.5%
SRTS's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
SRTS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$53.7M
Liabilities
$4.9M
Debt to equity
0.1
SRTS's short-term assets ($49.53M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SRTS's short-term assets ($49.53M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SRTS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SRTS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$2.7M
Investing
$0.0
Financing
-$7.0k
SRTS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SRTS vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
SRTS$55.41M+7.64%112.67x1.13x
RBOT$55.01M-4.28%-0.64x0.56x
IRIX$54.45M-4.01%-5.68x5.72x
NSPR$54.42M-0.85%-2.83x1.38x
AMIX$53.75M+3.25%N/A-9.61x

Sensus Healthcare Stock FAQ

What is Sensus Healthcare's quote symbol?

(NASDAQ: SRTS) Sensus Healthcare trades on the NASDAQ under the ticker symbol SRTS. Sensus Healthcare stock quotes can also be displayed as NASDAQ: SRTS.

If you're new to stock investing, here's how to buy Sensus Healthcare stock.

What is the 52 week high and low for Sensus Healthcare (NASDAQ: SRTS)?

(NASDAQ: SRTS) Sensus Healthcare's 52-week high was $5.38, and its 52-week low was $1.79. It is currently -37.17% from its 52-week high and 88.83% from its 52-week low.

How much is Sensus Healthcare stock worth today?

(NASDAQ: SRTS) Sensus Healthcare currently has 16,394,171 outstanding shares. With Sensus Healthcare stock trading at $3.38 per share, the total value of Sensus Healthcare stock (market capitalization) is $55.41M.

Sensus Healthcare stock was originally listed at a price of $5.85 in Jul 26, 2016. If you had invested in Sensus Healthcare stock at $5.85, your return over the last 7 years would have been -42.22%, for an annualized return of -7.54% (not including any dividends or dividend reinvestments).

How much is Sensus Healthcare's stock price per share?

(NASDAQ: SRTS) Sensus Healthcare stock price per share is $3.38 today (as of Apr 12, 2024).

What is Sensus Healthcare's Market Cap?

(NASDAQ: SRTS) Sensus Healthcare's market cap is $55.41M, as of Apr 15, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Sensus Healthcare's market cap is calculated by multiplying SRTS's current stock price of $3.38 by SRTS's total outstanding shares of 16,394,171.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.